2 blue chip ASX shares rated as buys

ResMed Inc. (ASX:RMD) and this ASX blue chip share could be quality options for ASX investors. Here's why they are rated as buys…

| More on:
Blue chips falling.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you wanting to buy some blue chip ASX shares for your portfolio? Then you might want to check out the ones listed below.

These quality companies have been tipped as blue chips to buy. Here's what you need to know:

BHP Group Ltd (ASX: BHP)

The first blue chip share to look at is mining giant BHP. If you're looking for exposure to the resources sector, BHP could be a great way to do it.

This is due to the quality of the Big Australian's diverse operations and favourable commodity prices. The latter is particularly the case for iron ore, with the steel making ingredient recently hitting record highs. And while it has pulled back since then, it is still generating significant free cash flow from current prices.

This is likely to lead to bumper earnings and dividend payments for shareholders in FY 2021 and FY 2022.

Macquarie expects this to be the case and has put an outperform rating and $57.00 price target on its shares.

ResMed Inc. (ASX: RMD)

Another blue chip for investors to consider is ResMed. It is a medical device company with a focus on sleep disorders.

Although the pandemic has negatively impacted sleep disorder diagnoses and referrals, ResMed has continued to grow at a solid rate over the last 12 months.

Pleasingly, ResMed still has a long runway for growth over the next decade and beyond. In fact, management has set itself a goal of improving 250 million lives in out-of-hospital healthcare in 2025.

Helping it achieve this goal will be its rapidly growing digital health ecosystem, which reached over 12 million cloud connectable medical devices in 2020. This provides ResMed with strong recurring and sticky revenues and high quality data.

Analysts at Credit Suisse are positive on the company. The broker currently has an outperform rating and $29.00 price target on its shares.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Blue Chip Shares

Excited couple celebrating success while looking at smartphone.
Blue Chip Shares

3 no-brainer ASX 200 shares to buy with $5,000

You don't need a brain to see that these shares could be quality investments.

Read more »

Three young people lie in the surf on a beach wearing santa hats.
Blue Chip Shares

BHP, Macquarie, and Westpac: Naughty or nice? 3 popular ASX shares examined

Let's see if these blue chips made their shareholders smile in 2025.

Read more »

Two men laughing while bouncing on bouncy balls
Blue Chip Shares

I think these ASX blue chips shares are primed for a major rebound in 2026

2025 was not kind to these shares. Here's why things could be better next year.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Blue Chip Shares

Is now the time to buy Pro Medicus shares?

After a 13% pullback, Pro Medicus shares are back in focus. Is this weakness an opportunity?

Read more »

Two strong women battle it out in the boxing ring.
Investing Strategies

Why these 2 battered ASX 200 stocks could shine in 2026

Bruised this year, but analysts see the heavyweight shares bounce back in 2026.

Read more »

A smiling woman holds a Facebook like sign above her head.
Blue Chip Shares

CSL and more blue-chip ASX 200 bargains I'd buy before 2026

Here's why I think these shares could be cheap buys before the end of the year.

Read more »

A happy couple drinking red wine in a vineyard.
Blue Chip Shares

What can investors expect from Treasury Wines' update tomorrow?

Tomorrow’s announcement is shaping up to be one of the most consequential updates in years for Treasury Wine Estates.

Read more »

man in old fashioned suit and hat looking through magnifying glass
Blue Chip Shares

Is the CSL share price a generational bargain at $180?

CSL shares are currently trading near a 7-year low.

Read more »